Presentation is loading. Please wait.

Presentation is loading. Please wait.

P53 restoration in a syngeneic transplant model of Mdm2Tg p53Neo/Neo CreER angiosarcoma. p53 restoration in a syngeneic transplant model of Mdm2Tg p53Neo/Neo.

Published bySelim Çağlayan Modified over 5 years ago

Similar presentations

Presentation on theme: "P53 restoration in a syngeneic transplant model of Mdm2Tg p53Neo/Neo CreER angiosarcoma. p53 restoration in a syngeneic transplant model of Mdm2Tg p53Neo/Neo."— Presentation transcript:

1 p53 restoration in a syngeneic transplant model of Mdm2Tg p53Neo/Neo CreER angiosarcoma.
p53 restoration in a syngeneic transplant model of Mdm2Tg p53Neo/Neo CreER angiosarcoma. A, growth curves of transplanted Mdm2Tg p53Neo/Neo CreER angiosarcomas treated with tamoxifen (n = 8) and vehicle control (n = 3). B, comparison of tumor volume doubling time calculated from tumor growth curves between tamoxifen-treated and vehicle control groups. Tumor volume doubling time was calculated based on the exponential curve fit of tumor volume against time. C, Western blot analysis of p53 and p21 levels in transplanted Mdm2Tg p53Neo/Neo CreER angiosarcomas treated with tamoxifen and vehicle control. Three representative tumors from both control and tamoxifen-treated groups were examined. Protein lysate from an Mdm2−/−p53−/− spleen served as negative control. D, qRT-PCR analysis of expression of p53 target genes p21 and Puma in transplanted Mdm2Tg p53Neo/Neo CreER angiosarcomas treated with tamoxifen and vehicle control. Data were normalized to expression in a vehicle-treated control. Qin Li et al. Mol Cancer Res 2014;12: ©2014 by American Association for Cancer Research

Download ppt "P53 restoration in a syngeneic transplant model of Mdm2Tg p53Neo/Neo CreER angiosarcoma. p53 restoration in a syngeneic transplant model of Mdm2Tg p53Neo/Neo."

Similar presentations

25(OH)D and 1,25(OH)2D perfusion treatment effect on cancer-related markers: IF stains illustrating expression levels for Ki-67 (A), cyclin D1 (B), ErbB-2.

25(OH)D and 1,25(OH)2D perfusion treatment effect on cancer-related markers: IF stains illustrating expression levels for Ki-67 (A), cyclin D1 (B), ErbB-2.
Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.

Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.
Inhibition of FGFR signaling and tumor growth in SNU-16 xenograft model by administration of E7090. Inhibition of FGFR signaling and tumor growth in SNU-16.

Inhibition of FGFR signaling and tumor growth in SNU-16 xenograft model by administration of E7090. Inhibition of FGFR signaling and tumor growth in SNU-16.
CHK1 downregulation upon ERG overexpression.

CHK1 downregulation upon ERG overexpression.
Comparison of protein synthesis patterns of L

Comparison of protein synthesis patterns of L
Increase in beige/brown adipocyte characteristics in the xenografts from additional breast cancer cell lines. Increase in beige/brown adipocyte characteristics.

Increase in beige/brown adipocyte characteristics in the xenografts from additional breast cancer cell lines. Increase in beige/brown adipocyte characteristics.
Collagen-dependent phosphorylation of eIF4E in PDAC cells.

Collagen-dependent phosphorylation of eIF4E in PDAC cells.
Overexpression of HGF decreases MET protein levels.

Overexpression of HGF decreases MET protein levels.
Effect of MI-773 and/or cisplatin in a preclinical model of ACC

Effect of MI-773 and/or cisplatin in a preclinical model of ACC
Expression changes of specific epigenetic-controlled tumor-related genes by the prenatal/maternal BSp treatment. qRT-PCR and Western blot analysis were.

Expression changes of specific epigenetic-controlled tumor-related genes by the prenatal/maternal BSp treatment. qRT-PCR and Western blot analysis were.
eIF5A-PEAK1 signaling regulates KRAS protein expression.

eIF5A-PEAK1 signaling regulates KRAS protein expression.
Effect of MI-773 dosing on long-term efficacy.

Effect of MI-773 dosing on long-term efficacy.
Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.

Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.
SIRT1 is downregulated in human gastric cancer (GC).

SIRT1 is downregulated in human gastric cancer (GC).
Effects of Z-FA-FMK on SMN protein expression in type II SMA patient fibroblast cells (GM22592). Effects of Z-FA-FMK on SMN protein expression in type.

Effects of Z-FA-FMK on SMN protein expression in type II SMA patient fibroblast cells (GM22592). Effects of Z-FA-FMK on SMN protein expression in type.
ONC201 activates the ISR. ONC201 activates the ISR. (A) Western blotting analysis for ATF4, CHOP, ATF3, and TRB3 on lysates from HCT116 cells cultured.

ONC201 activates the ISR. ONC201 activates the ISR. (A) Western blotting analysis for ATF4, CHOP, ATF3, and TRB3 on lysates from HCT116 cells cultured.
Accumulation of ubiquitinated MDM2 following PN treatment requires the PIKK ATM. A, Western blots of nuclear extract proteins from ZR-75-1 cells treated.

Accumulation of ubiquitinated MDM2 following PN treatment requires the PIKK ATM. A, Western blots of nuclear extract proteins from ZR-75-1 cells treated.
Targeting eIF4E increases ZEB1 protein and mRNA levels and decreases ZEB1-targeting miR-200c and miR-141 microRNAs. Targeting eIF4E increases ZEB1 protein.

Targeting eIF4E increases ZEB1 protein and mRNA levels and decreases ZEB1-targeting miR-200c and miR-141 microRNAs. Targeting eIF4E increases ZEB1 protein.
Aberrant regulation of HDAC2 and its association with malignant proliferation of human gastric cancer. Aberrant regulation of HDAC2 and its association.

Aberrant regulation of HDAC2 and its association with malignant proliferation of human gastric cancer. Aberrant regulation of HDAC2 and its association.
GA blocks HIF activity and reduces HIF target expression.

GA blocks HIF activity and reduces HIF target expression.

Similar presentations

Ads by Google